Taletrectinib: Transforming Outcomes in ROS1-Positive Non- Small Cell Lung Cancer

Authors

  • Ayesha Khan Dow University of Health Sciences, Pakistan .
  • Natasha Partab Rai Dow University of Health Sciences, Pakistan.
  • Samana Batool Dow University of Health Sciences, Pakistan.

DOI:

https://doi.org/10.31557/APJCN.2208.20261021

Keywords:

Antineoplastic agents, non-small-cell lung carcinoma, proto-oncogene proteins c-ros, TRUST-I clinical trial, TRUST-II clinical trial

Abstract

-

Downloads

Published

2026-10-21

How to Cite

Khan, A., Rai, N. P., & Batool, S. (2026). Taletrectinib: Transforming Outcomes in ROS1-Positive Non- Small Cell Lung Cancer. Asian Pacific Journal of Cancer Nursing, 20261021. https://doi.org/10.31557/APJCN.2208.20261021

Issue

Asian Pacific Journal of Cancer Nursing

Section

Commentaries/ letter to editor

License

Copyright (c) 2026 Asian Pacific Journal of Cancer Nursing

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.